Tag: Parsabiv
Amgen’s Parsabiv gets EC approval for treating SHPT
American biopharma company Amgen’s Parsabiv drug has been approved by the European Commission for treating secondary hyperparathyroidism. Secondary Hyperparathyroidism (sHPT) is a serious and chronic ... Read More